Evergreen Nephrology Welcomes New CEO
Evergreen Nephrology has recently announced the exciting appointment of John Donlan as the company's Chief Executive Officer. With decades of experience in the healthcare sector, Donlan is set to lead the organization to new heights.
Leadership Experience
Bringing over 30 years of healthcare experience to the table, John Donlan has dedicated a significant portion of his career to advancing physician practices within value-based care frameworks. His impressive track record includes the implementation of successful national growth strategies that have effectively improved population health outcomes and enhanced the performance of ACO provider networks.
A Proven Track Record
Among his notable accomplishments, Donlan previously served as President of Steward Health Care Network. Under his leadership, Steward became one of the initial CMMI Pioneer ACOs established under the Affordable Care Act and successfully launched the first Medicaid ACO program in the region. Steward's primary care physician-led model consistently received accolades for being a top-performing ACO, a testament to Donlan's effective leadership.
Strategic Focus and Vision
The Executive Chairman of Evergreen Nephrology, Adam Boehler, commented on the appointment, stating, "John's extensive experience in value-based care, visionary leadership, and talent for scaling healthcare organizations make him the ideal leader for Evergreen. Under John's guidance, we are excited about the potential to innovate and expand, ultimately resulting in improved outcomes for our patients and communities."
Goals for the Future
In his role as CEO, Donlan aims to spearhead Evergreen's national expansion while simultaneously working towards enhancing health outcomes and minimizing medical expenses within value-based care programs. His leadership is vital to advancing the organization's mission of improving the lives of individuals affected by kidney disease.
Strengthening the Leadership Team
Donlan joins Evergreen at a time of significant growth, as the company strengthens its leadership team to amplify its impact in the healthcare sector. In addition to Donlan’s appointment, Evergreen has seen the addition of four pivotal executives in recent months, including Heather Trafton as President and Philip Cooksey as Chief Financial Officer.
Key Executive Contributions
Trafton’s vast expertise in clinical operations and value-based care models will enhance Evergreen's ability to support physicians effectively. Meanwhile, Cooksey's extensive financial oversight experience, which includes leadership roles at Humana and investment banking with Goldman Sachs, will fortify Evergreen's financial strategy. Tim Pflederer, a distinguished nephrologist and former President of the Renal Physicians Association, will drive clinical excellence as Chief Medical Officer. Additionally, Ron Margalit, with 25 years of experience in healthcare technology, will focus on advancing initiatives that enhance the company’s value-based care capabilities.
Commitment to Value-Based Care
These strategic appointments, paired with Evergreen’s recently signed value-based care partnership, reinforce the company’s dedication to expanding its collaborative efforts in delivering high-quality and personalized care to patients nationwide.
John Donlan's Commitment
Expressing his enthusiasm about joining the company, Donlan remarked, "I am truly honored to take on this role at Evergreen Nephrology during such a pivotal time. I am passionate about transforming nephrology care and improving patient outcomes through effective value-based care models. Together with my talented colleagues at Evergreen, we will forge a path toward innovation, broaden our reach, and make a lasting impact on patients' lives."
About Evergreen Nephrology
Evergreen Nephrology is dedicated to a patient-centered approach in kidney care by collaborating with nephrologists and payor partners to create a comprehensive experience for those living with chronic and end-stage kidney disease. By facilitating shared decision-making, Evergreen empowers patients to take an active role in their health journey. With a network of over 850 provider partners across numerous states, the organization is setting a new national standard for personalized and physician-led kidney care.
Frequently Asked Questions
Who is John Donlan?
John Donlan is the newly appointed CEO of Evergreen Nephrology with over 30 years of experience in healthcare.
What are John Donlan's priorities as CEO?
His main goals include expanding Evergreen's national presence and enhancing health outcomes in value-based care programs.
What experience does Donlan bring to Evergreen Nephrology?
He has extensive leadership experience in healthcare, specifically in value-based care and physician-led networks.
What does Evergreen Nephrology focus on?
Evergreen Nephrology emphasizes a patient-centered approach and works to provide holistic care for kidney disease patients.
What is Evergreen's commitment to value-based care?
Evergreen is dedicated to expanding its value-based care partnerships and delivering high-quality, personalized care to patients.
